STANFORD, Calif., Dec. 24, 2025 /PRNewswire/ -- The NANOscientific Symposium Series (NSS) 2025 has successfully concluded its global program, bringing together…
Acclaimed oncologist from Roswell Park Comprehensive Cancer Center to help lead nonprofit responsible for gold standard guidelines that define and…
SHANGHAI, Oct. 30, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced the initiation of a Phase II…
- New research confirms Jungbunzlauer's TCC TB supports efficient, high-quality tablet manufacturing across challenging pharmaceutical and nutraceutical applications - BASEL,…
HONG KONG, Oct. 21, 2025 /PRNewswire/ -- The Shaw Prize presented its awards to four 2025 Shaw Laureates today at…
VIENNA, Oct. 15, 2025 /PRNewswire/ -- The 61st Annual Meeting of the European Association for the Study of Diabetes (EASD…
HONG KONG, Sept. 14, 2025 /PRNewswire/ -- A high-level delegation from The Hong Kong University of Science and Technology (HKUST),…
BEIJING, July 22, 2025 /PRNewswire/ -- The 2025 International Congress of Basic Science (ICBS) officially kicked off on July 13…
PORTOLA VALLEY, Calif., June 12, 2025 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research…
The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive, HER2-negative advanced…